Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonafarnib, Pravastatin, and Zoledronic Acid in HGPS
NCT00916747Phase 2Unknown
- Sponsor
- Boston Children's Hospital
- Start
- Aug 2009
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lonafarnib in Hutchinson-Gilford progeria syndrome (HGPS), progeroid laminopathy, sponsored by Boston Children's Hospital. Status: unknown.
02
Drugs
lonafarnib
03
Conditions
Hutchinson-Gilford progeria syndrome (HGPS)progeroid laminopathy
Beyond the preview
Go deeper on NCT00916747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00916747.